Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2016

Open Access 01-12-2016 | Short report

Antimicrobial resistance profiles of Shiga toxin-producing Escherichia coli O157 and Non-O157 recovered from domestic farm animals in rural communities in Northwestern Mexico

Authors: Bianca A. Amézquita-López, Beatriz Quiñones, Marcela Soto-Beltrán, Bertram G. Lee, Jaszemyn C. Yambao, Ofelia Y. Lugo-Melchor, Cristóbal Chaidez

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2016

Login to get access

Abstract

Background

Antimicrobial resistance in Shiga toxin-producing Escherichia coli (STEC) O157 and non-O157 is a matter of increasing concern. The aim of the present study was to investigate the antimicrobial resistance profiles of STEC O157 and non-O157 recovered from feces of domestic farm animals in the agricultural Culiacan Valley in Northwestern Mexico.

Findings

All of the examined STEC strains showed susceptibility to five antimicrobials, ceftazidime, ceftriaxone, ciprofloxacin, nalidixic acid, and trimethoprim-sulfamethoxazole. However, resistance to the four antimicrobials, ampicillin, cephalothin, chloramphenicol, and kanamycin was commonly observed. Interestingly, non-susceptibility to cephalothin was predominant among the examined STEC strains, corresponding to 85 % (22/26) of the O157:H7 from cattle, sheep and chicken and 73 % (24/33) of the non-O157 strains from cattle and sheep. Statistical analyses revealed that resistance to ampicillin was significantly correlated to 38 % (10/26) of STEC O157:H7 strains from multiple animal sources. Another significant correlation was found between serotype, source, and antimicrobial resistance; all of the O20:H4 strains, recovered from sheep, were highly resistant to tetracycline. Multidrug resistance profiles were identified in 42 % (22/53) of the non-susceptible STEC strains with clinically-relevant serotypes O8:H9, O75:H8, O146:H21, and O157:H7.

Conclusions

STEC O157 and non-O157 strains, recovered from domestic farm animals in the Culiacan Valley, exhibited resistance to classes of antimicrobials commonly used in Mexico, such as aminoglycosides, tetracyclines, cephalosporins and penicillin but were susceptible to fluoroquinolones, quinolones, and sulfonamides. These findings provide fundamental information that would aid in the surveillance of antimicrobial resistance in an important agricultural region in Northwestern Mexico.
Appendix
Available only for authorised users
Literature
6.
go back to reference Murillo Llanes J, Varon J, Félix JSV, González-Ibarra FP. Antimicrobial resistance of Escherichia coli in Mexico: how serious is the problem? J Infect Dev Ctries. 2012;6(2):126–31. doi:10.3855/jidc.1525.PubMed Murillo Llanes J, Varon J, Félix JSV, González-Ibarra FP. Antimicrobial resistance of Escherichia coli in Mexico: how serious is the problem? J Infect Dev Ctries. 2012;6(2):126–31. doi:10.​3855/​jidc.​1525.PubMed
10.
go back to reference Bielaszewska M, Idelevich EA, Zhang W, Bauwens A, Schaumburg F, Mellmann A, et al. Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain. Antimicrob Agents Chemother. 2012;56(6):3277–82. doi:10.1128/aac.06315-11.PubMedCentralCrossRefPubMed Bielaszewska M, Idelevich EA, Zhang W, Bauwens A, Schaumburg F, Mellmann A, et al. Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain. Antimicrob Agents Chemother. 2012;56(6):3277–82. doi:10.​1128/​aac.​06315-11.PubMedCentralCrossRefPubMed
11.
12.
go back to reference Zhang X, McDaniel AD, Wolf LE, Keusch GT, Waldor MK, Acheson DW. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis. 2000;181(2):664–70. doi:10.1086/315239.CrossRefPubMed Zhang X, McDaniel AD, Wolf LE, Keusch GT, Waldor MK, Acheson DW. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis. 2000;181(2):664–70. doi:10.​1086/​315239.CrossRefPubMed
16.
18.
go back to reference Canizalez-Román A, González-Nuñez E, Vidal JE, Flores-Villaseñor H, León-Sicairos N. Prevalence and antibiotic resistance profiles of diarrheagenic Escherichia coli strains isolated from food items in Northwestern Mexico. Int J Food Microbiol. 2013;164(1):36–45. doi:10.1016/j.ijfoodmicro.2013.03.020.CrossRefPubMed Canizalez-Román A, González-Nuñez E, Vidal JE, Flores-Villaseñor H, León-Sicairos N. Prevalence and antibiotic resistance profiles of diarrheagenic Escherichia coli strains isolated from food items in Northwestern Mexico. Int J Food Microbiol. 2013;164(1):36–45. doi:10.​1016/​j.​ijfoodmicro.​2013.​03.​020.CrossRefPubMed
19.
go back to reference Homedes N, Ugalde A. Mexican pharmacies and antibiotic consumption at the US-Mexico border. South Med Rev. 2012;5(2):9–19.PubMedCentralPubMed Homedes N, Ugalde A. Mexican pharmacies and antibiotic consumption at the US-Mexico border. South Med Rev. 2012;5(2):9–19.PubMedCentralPubMed
23.
go back to reference Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 24th informational supplement. Wayne: CLSI Document M100-S24; 2014. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 24th informational supplement. Wayne: CLSI Document M100-S24; 2014.
24.
go back to reference Mehta CR, Patel NR. Algorithm 643. FEXACT: a FORTRAN subroutine for Fisher’s exact test on unordered r×c contingency tables. ACM Trans Math Softw. 1986;12(2):154–61. doi:10.1145/6497.214326.CrossRef Mehta CR, Patel NR. Algorithm 643. FEXACT: a FORTRAN subroutine for Fisher’s exact test on unordered r×c contingency tables. ACM Trans Math Softw. 1986;12(2):154–61. doi:10.​1145/​6497.​214326.CrossRef
25.
go back to reference Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81. doi:10.1111/j.1469-0691.2011.03570.x.CrossRefPubMed Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–81. doi:10.​1111/​j.​1469-0691.​2011.​03570.​x.CrossRefPubMed
Metadata
Title
Antimicrobial resistance profiles of Shiga toxin-producing Escherichia coli O157 and Non-O157 recovered from domestic farm animals in rural communities in Northwestern Mexico
Authors
Bianca A. Amézquita-López
Beatriz Quiñones
Marcela Soto-Beltrán
Bertram G. Lee
Jaszemyn C. Yambao
Ofelia Y. Lugo-Melchor
Cristóbal Chaidez
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2016
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-015-0100-5

Other articles of this Issue 1/2016

Antimicrobial Resistance & Infection Control 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.